Which stem cell type is most frequently discussed for Autism Spectrum Disorder (ASD) treatment?
Answer
Mesenchymal Stem Cells (MSCs)
Mesenchymal Stem Cells (MSCs) are identified as the cell type most commonly referenced in discussions surrounding stem cell applications for neurological conditions like autism. The rationale for using MSCs is rooted in their significant biological capabilities, specifically their capacity to modulate the immune system and reduce inflammation within the body. Furthermore, researchers hypothesize that these cells contribute to neuroprotection or facilitate neuroregeneration within the brain environment. The source material for these MSCs is also a tracked variable, frequently being derived from sources such as bone marrow or umbilical cord blood.
Related Questions
What is the current clinical status of stem cell therapy for Autism Spectrum Disorder (ASD)?Which stem cell type is most frequently discussed for Autism Spectrum Disorder (ASD) treatment?What common sources are cited for the Mesenchymal Stem Cells (MSCs) administered for ASD therapy?What specific functional domains commonly show reported positive outcomes after stem cell administration for autism?Which assessment tool represents a standardized, objective metric for measuring ASD core deficits post-treatment?According to published medical literature, how do stem cells primarily mediate their effects in ASD?How is stem cell administration often framed in relation to established interventions like Applied Behavior Analysis (ABA)?What is the reported short-term safety profile for administering autologous or allogeneic MSCs?What critical element should a mandatory post-treatment plan include when evaluating a stem cell clinic checklist?What causes divergence between perceived success rates and objective clinical success rates for stem cell therapy?